Walleye Capital LLC Bausch Health Companies Inc. Put Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $1,566 - $2,478	-300 Reduced 1.54%	19,200 $156,000
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $103,090 - $175,929	16,900 Added 650.0%	19,500 $135,000
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $20,202 - $27,586	2,600 New	2,600 $27,000
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $2,288 - $3,520	400 New	400 $3,000
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $63,336 - $82,472	10,400 New	10,400 $65,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $255,552 - $393,792	-19,200 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $612,656 - $1.43 Million	-47,200 Reduced 71.08%	19,200 $298,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $1.18 Million - $1.99 Million	-62,400 Reduced 48.45%	66,400 $1.99 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $2.02 Million - $2.49 Million	96,900 Added 303.76%	128,800 $2.81 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $543,780 - $700,925	26,500 Added 490.74%	31,900 $805,000
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $109,242 - $141,966	5,400 New	5,400 $133,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.72B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.